Otsuka Holdings (BMV:4578 N) - Stock Price, News & Analysis

4578 N Stock Overview

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. More details

4578 N fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	2/6
Past Performance	1/6
Financial Health	6/6
Dividends	3/6

Rewards

Earnings are forecast to grow 11.6% per year

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results

Otsuka Holdings Co., Ltd. Competitors

Genomma Lab Internacional. de

BMV:LAB B

Mex$24.7b

Takeda Pharmaceutical

TSE:4502

JP¥6.5t

UCB

ENXTBR:UCB

€34.1b

Zhangzhou Pientzehuang Pharmaceutical

SHSE:600436

CN¥142.4b

Price History & Performance

Summary of all time highs, changes and price drops for Otsuka Holdings
Historical stock prices
Current Share Price	JP¥1,189.07
52 Week High	JP¥1,247.81
52 Week Low	JP¥761.11
Beta	0.20
11 Month Change	-4.71%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	56.23%

Recent updates

Shareholder Returns

	4578 N	MX Pharmaceuticals	MX Market
7D	-4.7%	-1.3%	-0.3%
1Y	n/a	-19.3%	-4.0%

Return vs Industry: Insufficient data to determine how 4578 N performed against the MX Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 4578 N performed against the MX Market.

Price Volatility

Is 4578 N's price volatile compared to industry and market?
4578 N volatility
4578 N Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.7%
Market Average Movement	4.0%
10% most volatile stocks in MX Market	6.1%
10% least volatile stocks in MX Market	2.7%

Stable Share Price: 4578 N's share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine 4578 N's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1921	34,388	Tatsuo Higuchi	www.otsuka.com

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products.

Otsuka Holdings Co., Ltd. Fundamentals Summary

How do Otsuka Holdings's earnings and revenue compare to its market cap?
4578 N fundamental statistics
Market cap	Mex$634.85b
Earnings (TTM)	Mex$20.05b
Revenue (TTM)	Mex$300.20b

31.7x

P/E Ratio

2.1x

P/S Ratio

Is 4578 N overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4578 N income statement (TTM)
Revenue	JP¥2.27t
Cost of Revenue	JP¥648.61b
Gross Profit	JP¥1.62t
Other Expenses	JP¥1.47t
Earnings	JP¥151.58b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 14, 2025

Earnings per share (EPS)	281.38
Gross Margin	71.42%
Net Profit Margin	6.68%
Debt/Equity Ratio	10.1%

How did 4578 N perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

43%

Payout Ratio

Otsuka Holdings BMV:4578 N Stock Report